Evidence map›Paper›PMID 32109157›Full record

ArticleJCO global oncology2020

Surgical Trends in Breast Cancer in Turkey: An Increase in Breast-Conserving Surgery.

Güldeniz Karadeniz Çakmak, Selman Emiroğlu, Atakan Sezer, Nuh Zafer Canturk, Levent Yeniay, Bekir Kuru, Hasan Karanlık, Aykut Soyder, Şehsuvar Gökgöz, Gürhan Sakman and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JCO global oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Güldeniz Karadeniz ÇakmakDepartment of Surgery, The School of Medicine, Zonguldak Bulent Ecevit University, Zonguldak, Turkey.
Selman EmiroğluDepartment of Surgery, Istanbul Medical School, Istanbul University, Istanbul, Turkey.
Atakan SezerDepartment of Surgery, The School of Medicine, Trakya University, Edirne, Turkey.
Nuh Zafer CanturkDepartment of Surgery, The School of Medicine, Kocaeli University, Kocaeli, Turkey.
Levent YeniayDepartment of Surgery, The School of Medicine, Ege University, Izmir, Turkey.
Bekir KuruDepartment of Surgery, The School of Medicine, Ondokuz Mayıs University, Samsun, Turkey.
Hasan KaranlıkOncology Institute, Istanbul University, Istanbul, Turkey.
Aykut SoyderDepartment of Surgery, The School of Medicine, Adnan Menderes University, Aydın, Turkey.
Şehsuvar GökgözDepartment of Surgery, The School of Medicine, Uludag University, Bursa, Turkey.
Gürhan SakmanDepartment of Surgery, The School of Medicine, Cukurova University, Adana, Turkey.
Muhammed UcuncuIstanbul Florence Nightingale Hospital, Istanbul, Turkey.
Mufide Nuran AkcayDepartment of Surgery, The School of Medicine, Ataturk University, Erzurum, Turkey.
Sadullah GirginDepartment of Surgery, The School of Medicine, Dicle University, Diyarbakır, Turkey.
Sibel Ozkan GurdalDepartment of Surgery, The School of Medicine, Namık Kemal University, Tekirdag, Turkey.
Mustafa EmirogluIzmir Tepecik Education and Research Hospital, Izmir, Turkey.
Serdar OzbasGuven Hospital, Ankara, Turkey.
Abdullah Bahadir ÖzDepartment of Surgery, The School of Medicine, Erciyes University, Kayseri, Turkey.
Cumhur AriciDepartment of Surgery, The School of Medicine, Akdeniz University, Antalya, Turkey.
Osman ToktasDepartment of Surgery, The School of Medicine, Van Yüzüncü Yil University, Van, Turkey.
Orhan DemircanAcibadem Adana Hospital, Adana, Turkey.
Adnan ÇalıkDepartment of Surgery, The School of Medicine, Karadeniz Teknik University, Trabzon, Turkey.
Ayfer Kamali PolatDepartment of Surgery, The School of Medicine, Ondokuz Mayıs University, Samsun, Turkey.
Gokturk MaralcanDepartment of Surgery, The School of Medicine, Sanko University, Gaziantep, Turkey.
Seher DemirerDepartment of Surgery, The School of Medicine, Ankara University, Ankara, Turkey.
Vahit OzmenDepartment of Surgery, Istanbul Medical School, Istanbul University, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeBreast cancer is the most frequent cancer in women, and there is a great variability in surgical practice for treating that cancer in different countries. The aims of this study were to analyze the effect of guidelines from the Turkish Federation of Breast Diseases Societies on academic institutions that have breast centers and to evaluate surgical practice in Turkey in 2018. PATIENTS AND

methodsBetween January and March 2019, a survey was sent to breast surgeons who were working in breast centers in academic institutions. The sampling frame included 24 academic institutions with breast centers in 18 cities in Turkey to evaluate interdisciplinary differences among breast centers and seven regions in Turkey regarding patients' choices, surgical approaches, and academic institutions.

resultsAll surgeons responded to the survey, and all 4,381 patients were included. Most of the surgeons (73.9%) were working in a breast center. Multidisciplinary tumor boards were performed in 87% of the breast centers. The average time between clinical evaluation and initiation of treatment was 29 days; the longest time was in Southeast Anatolia (66 days). Only 6% of patients had ductal carcinoma in situ. Sentinel lymph node biopsy was available in every region across the country and was performed in 64.5% of the patients. In 2018, the overall breast-conserving surgery rate was 57.3% in Turkey, and it varied from 72.2% in the Black Sea region to 33.5% in Central Anatolia (

conclusionIncreasing rates of nonpalpable breast cancer and decreasing rates of locoregional recurrences favored breast-conserving surgery, especially in developed countries. Guidelines from the Turkish Federation of Breast Diseases Societies resulted in more comprehensive breast centers and improved breast health in Turkey.

Indexed as

Breast NeoplasmsMastectomy, SegmentalBlack SeaFemaleHumansNeoplasm Recurrence, LocalTurkey

Identifiers

PMID32109157
PMCPMC7051798

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.